- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IDO1 Inhibitor BMS-986205
Total 1685 results
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownChronic Lymphocytic LeukemiaNetherlands
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
National Cancer Institute (NCI)CompletedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Limited Stage Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedHepatic InsufficiencyUnited States
-
Bristol-Myers SquibbCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Bristol-Myers SquibbCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mycosis Fungoides | MultipleUnited States
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicJapan
-
M.D. Anderson Cancer CenterRecruitingRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Korea, Republic of, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, United Kingdom, Czechia, Denmark, Germany, Poland
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedRenal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States, Argentina, Brazil, Australia, Singapore, New Zealand, Russian Federation, Mexico, Peru, Chile
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Canada, Italy, Netherlands, Spain, Israel
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; AstraZenecaTerminated
-
Medstar Health Research InstituteBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedLeukemiaFrance, United States, Spain, Poland, Finland, Argentina, Canada, Belgium
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Myelofibrosis | Leukemia, Myelomonocytic, Chronic | Hypereosinophilic Syndrome | Mastocytosis | Agnogenic Myeloid MetaplasiaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMyeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Lymphoid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
National Institutes of Health Clinical Center (CC)Bristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...Completed
-
Bristol-Myers SquibbWithdrawn
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Salivary Gland Carcinoma | Salivary Gland Adenoid Cystic Carcinoma | Stage IV Major Salivary Gland Cancer AJCC v7 | Malignant Salivary Gland NeoplasmUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Bristol-Myers SquibbCompletedSclerodermaUnited States
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
National Cancer Institute (NCI)CompletedSquamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
Andrew J. Armstrong, MDBristol-Myers SquibbRecruitingMetastatic Prostate Cancer | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
University of California, DavisPharmacyclics LLC.CompletedMetastatic Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Bristol-Myers SquibbPfizerCompletedThromboembolismUnited States, Canada, Mexico, Israel, Australia